Th17 cells from approximately 50% of individuals with PCC had no capacity to express IL-17A and IL-22, similar to individuals with critical COVID-19, which would prevent clearing extracellular pathogens. This evidence concerns the gene IL17A and adrenal gland pheochromocytoma.